Emerging drugs for the management of cancer treatment induced bone loss

Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial

(2014) John T. Grbic et al.   JOURNAL OF THE AMERICAN DENTAL ASSOCIATION

Denosumab in Osteoporosis and Oncology

(2009) Jill S Burkiewicz et al.   ANNALS OF PHARMACOTHERAPY

Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency

(2009) Heike A. Bischoff-Ferrari et al.   ARCHIVES OF INTERNAL MEDICINE

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies

(2009) Anselm Mak et al.   BMC MUSCULOSKELETAL DISORDERS

25-hydroxy vitamin D levels in healthy premenopausal women: Association with bone turnover markers and bone mineral density

(2009) Silvano Adami et al.   BONE

Bone turnover markers in postmenopausal breast cancer treated with fulvestrant – A pilot study

(2009) A. Agrawal et al.   BREAST

Assessment of Circulating Dickkopf-1 with a New Two-Site Immunoassay in Healthy Subjects and Women with Breast Cancer and Bone Metastases

(2009) Nathalie Voorzanger-Rousselot et al.   CALCIFIED TISSUE INTERNATIONAL

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk

(2009) Lu Yin et al.   Cancer Epidemiology

Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?

(2009) Orit C. Freedman et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Future therapeutic targets in osteoporosis

(2009) Chad Deal   CURRENT OPINION IN RHEUMATOLOGY

Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?

(2009) R.E. Coleman   EUROPEAN JOURNAL OF CANCER

Effects of Arzoxifene on Bone Mineral Density and Endometrium in Postmenopausal Women with Normal or Low Bone Mass

(2009) M. Bolognese et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy

(2009) Katherine D. Crew et al.   JOURNAL OF CLINICAL ONCOLOGY

Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy

(2009) Nirmala Bhoopalam et al.   JOURNAL OF UROLOGY

Zoledronic acid prevents bone loss in early-stage breast cancer

(2009) Francesco Bertoldo et al.   Nature Reviews Clinical Oncology

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

(2009) Matthew R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global vitamin D status and determinants of hypovitaminosis D

(2009) A. Mithal et al.   OSTEOPOROSIS INTERNATIONAL

Strontium ranelate improves bone microarchitecture in osteoporosis

(2009) N. A. T. Hamdy   RHEUMATOLOGY

Risedronate Recovers Bone Loss in Patients With Prostate Cancer Undergoing Androgen-deprivation Therapy

(2009) Kouji Izumi et al.   UROLOGY

Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

(2008) Bent Kristensen et al.   ACTA ONCOLOGICA

Practical guidance for the management of aromatase inhibitor-associated bone loss

(2008) P. Hadji et al.   ANNALS OF ONCOLOGY

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

(2008) Nigel J. Bundred et al.   CANCER

Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies

(2008) Robert E. Coleman et al.   CANCER TREATMENT REVIEWS

Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group

(2008) David M. Reid et al.   CANCER TREATMENT REVIEWS

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

(2008) J. E. Lester et al.   CLINICAL CANCER RESEARCH

Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom

(2008) B Rack et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

(2008) Arlene M Gallagher et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*

(2008) Stuart L Silverman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States

(2008) Sarah J Glover et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis

(2008) Pauline M. Camacho et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer

(2008) Georgiana K. Ellis et al.   JOURNAL OF CLINICAL ONCOLOGY

Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

(2008) Susan L. Greenspan et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

(2008) Richard Eastell et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer

(2008) Fred Saad et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

(2008) Stephanie L. Hines et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

(2008) Michael Gnant et al.   LANCET ONCOLOGY

Predominant role of 25OHD in the negative regulation of PTH expression: Clinical relevance for hypovitaminosis D

(2008) Masayuki Kawahara et al.   LIFE SCIENCES

Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women

(2008) Wen-Ling Lee et al.   MATURITAS

The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action

(2008) Michael F. Holick   MOLECULAR ASPECTS OF MEDICINE

Vitamin D status and response to treatment in post-menopausal osteoporosis

(2008) S. Adami et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study

(2007) M.R. Smith et al.   JOURNAL OF UROLOGY